As MCL-1 regulated the activity of Cofilin and the output of the SFKs in breast cancer cells, this led us to discover that drugs that antagonize MCL-1 can sensitize TNBC cells to dasatinib and suppress metastatic progression [15]. Here, CFL1 is linked to breast cancer.